MedTrace Logo

Clinical Evaluation of the Cochlear Nucleus CI532 Cochlear Implant in Adults

NCT03007472 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2020-12-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to gather long-term data on the FDA approved CI532 cochlear implant, and CP1000 (Nucleus 7) sound processor

Conditions

  • Hearing Loss, Sensorineural

Interventions

DEVICE

CI532

Cochlear implant

DEVICE

Nucleus 7

Sound processor

Sponsors & Collaborators

  • Cochlear

    lead INDUSTRY

Principal Investigators

  • Jillian Crosson, PhD · Senior Manager of Clinical Services

  • Megan Mears, AuD · Clinical Project Manager

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-15
Primary Completion
2018-12-03
Completion
2020-03-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03007472 on ClinicalTrials.gov